期刊
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY
卷 31, 期 1, 页码 17-24出版社
FRONTLINE MEDICAL COMMUNICATIONS
DOI: 10.1016/j.sder.2011.11.005
关键词
atopic dermatitis; eczema; treatment; therapy; medication; drug; topical; systemic; barrier cream; biologics; proactive therapy
Atopic dermatitis (AD) is a chronic inflammatory skin condition marked by intensely pruritic, eczematous changes. First-line therapy includes topical corticosteroids during an exacerbation and long-term emollient use, followed by topical calcineurin inhibitors, phototherapy, and systemic therapy in more difficult cases. The need for more effective AD therapies with safer side effect profiles has pushed researchers to devise new therapies and to recycle traditional treatments for use in a novel manner. Innovative therapies include barrier therapy, novel antistaphylococcal treatments, new immunomodulatory agents, unconventional antipruritic agents, exclusionary diets, and probiotics. Advancements in these options have paved the way for a targeted approach to AD therapy. We will review the latest clinical research exploring these cutting-edge AD treatment modalities and discuss forward-thinking therapy strategies that use conventional AD medications in a novel manner. Semin Cutan Med Surg 31:17-24 (C) 2012 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据